Prescription drug fatalities among women in rural Virginia: A study of medical examiner cases

Authors

  • Martha J. Wunsch, MD
  • Kent Nakamoto, PhD
  • Paul A. Nuzzo, MA
  • George Behonick, PhD
  • William Massello, MD
  • Sharon L. Walsh, PhD

DOI:

https://doi.org/10.5055/jom.2009.0025

Keywords:

prescription drugs, overdose, opioids, antidepressants, sedatives

Abstract

Objective: To evaluate female drug overdose deaths from the Office of the Chief Medical Examiner, Western Virginia (1997-2003) for demographics, medical history, toxicology results, and prescribed medications.
Design: Autopsy reports, death investigations, and hospital/physician notes were reviewed for 330 fatal drug poisonings among women. Data were evaluated with both qualitative and quantitative methods.
Results: Most decedents were Caucasian (95 percent), their average age was 42.8 years, and the predominant manner and cause of death was accidental and polydrug toxicity, respectively. Drugs were identified on toxicology or assigned as a cause of death in all 330 cases. The three most common drug classes detected on toxicology were opioids (n = 239; 72.4 percent), antidepressants (n = 201; 60.9 percent), and sedative/anxiolytic/muscle relaxant (SAMR) (n = 161; 48.8 percent) with all three drug classes detected in 89 (27 percent) cases. Illicit drugs identified included cocaine (n = 33; 10 percent) and heroin (n = 3; 0.9 percent). Prescriptions for opioids, SAMR, and antidepressants were found in decedent name in 48 percent, 67.1 percent, and 58 percent of cases, respectively, and 46.1 percent of cases were prescribed at least one medication from each of those three drug classes.
Conclusion: Although many decedents held prescriptions, and often for multiple drugs, toxicological findings indicate the frequent presence of other therapeutic drugs in the absence of a prescription. Moreover, many of these cases held simultaneous prescriptions for which there are known drug interactions. It is likely that misuse, fatal medication errors, abuse, and addiction were factors in the increased numbers of these deaths. Interventions to prevent prescription overdose deaths must involve education of both physicians and patients.

Author Biographies

Martha J. Wunsch, MD

Department of Behavioral Sciences, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky.

Kent Nakamoto, PhD

Department of Marketing, Pamplin College of Business, Blacksburg, Virginia.

Paul A. Nuzzo, MA

Department of Behavioral Sciences, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky.

George Behonick, PhD

University of Massachusetts Medical School, UMass Memorial Forensic Toxicology Laboratory, Worcester, Massachusetts.

William Massello, MD

North Dakota State Forensic Examiner, Bismarck, North Dakota.

Sharon L. Walsh, PhD

Department of Behavioral Sciences, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky.

References

Compton WM, Volkow ND: Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug Alcohol Depend. 2006; 81(2): 103-107.

SAMHSA: Results From the 2006 National Survey on Drug Use and Health. NSDUH Series H-32, DHHS Publication No. SMA 07-4293. Rockville, MD: SAMHSA, 2007.

SAMHSA: The DAWN Report: Oxycodone, Hydrocodone, and Polydrug Use, 2002. Rockville, MD: SAMHSA, 2004.

CDC: Unintentional and undetermined poisoning deaths-11 states, 1990-2001. MMWR Weekly. 2004; 53(11): 233-238.

Paulozzi LJ, Budnitz DS, Xi Y: Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf. 2006; 15(9): 618-627.

CDC: Unintentional poisoning deaths, 1999-2004. MMWR Weekly. 2007; 56(5): 93-98.

SAMHSA: Opiate-Related Drug Misuse Deaths in Six States: 2003. The New DAWN Report. Rockville MD: SAMHSA, 19: 2006.

Hall AJ, Logan JE, Toblin RL, et al.: Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008; 300(22): 2613-2620.

Wunsch MJ, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: A description of the high prevalence of accidental fatalities involving prescribed medications. Am J Addict. 2009; 18(1): 5-14.

OMB: BULLETIN NO. 07-01: Update of Statistical Area Definitions and Guidance on Their Uses. Washington DC: OMB, 2006.

NIH: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. NIH Publication 98-4083: National Institutes of Health, 1998.

Shah N, Lathrop SL, Landen MG: Unintentional methadonerelated overdose death in New Mexico (USA) and implications for surveillance, 1998-2002. Addiction. 2005; 100(2): 176-188.

Mueller MR, Shah NG, Landen MG: Unintentional prescription drug overdose deaths in New Mexico, 1994-2003. Am J Prev Med. 2006; 30(5): 423-429.

Drummer OH: Postmortem toxicology of drugs of abuse. Forensic Sci Int. 2004; 142(2-3): 101-113.

Cone EJ, Fant RV, Rohay JM, et al.: Oxycodone involvement in drug abuse deaths. II. Evidence for toxic multiple drug-drug interactions. J Anal Toxicol. 2004; 28(7): 616-624.

US Census Bureau: Census 2000 Redistricting Data (Public Law 94-171) Summary File, Matrices PL1 and PL2. US Government, 2000.

SAMHSA: Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Series H-34, DHHS Publication No. SMA 08-4343. Rockville, MD: SAMHSA, 2008.

Simoni-Wastila L, Ritter G, Strickler G: Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004; 39(1): 1-23.

Simoni-Wastila L, Yang HK: Psychoactive drug abuse in older adults. Am J Geriatr Pharmacother. 2006; 4(4): 380-394.

Gutstein HB, Akil H: Opioid analgesics. In Brunton LL, Lazo JS, Parker KL (eds.): Goodman and Gilman’s: The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: McGraw-Hill, 2006: 547-590.

Leavitt SB: Methadone-Drug* Interactions (*Medications, illicit drugs and other substances). Addiction Treatment Forum. Available at www.atforum.com/SiteRoot/pages/addiction_resources/Drug_Interactions.pdf. Accessed January 3, 2009.

Fishman SM: Responsible Opioid Prescribing: A Physician’s Guide. Washington, DC: Waterford Life Sciences, 2007: 13-100.

Gourlay DL, Heit HA, Almahrezi A: Universal precautions in pain medicine: a rational approach to the treatment of chronic pain. Pain Med. 2005; 6(2): 107-112.

Spina E, Santoro V, D’Arrigo C: Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: An update. Clin Ther. 2008; 30(7): 1206-1227.

Wunsch MJ, Boyd CJ, McMasters M: Nonmedical use of prescription medications. In Ries RFD, Miller SC, Saitz R (eds.) Principles of Addiction Medicine. 4th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2009.

Boyd CJ: Adolescents’ Nonmedical Use of Prescription Opioid Analgesics. “Pain, Opioids, and Addiction” An Urgent Problem for Doctors and Patients. Washington, DC: National Institute on Drug Abuse and American Heart Association, 2007.

Phillips BE: A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs. Arch Intern Med. 2008; 168(14): 1561-1566.

Published

01/29/2018

How to Cite

Wunsch, MD, M. J., K. Nakamoto, PhD, P. A. Nuzzo, MA, G. Behonick, PhD, W. Massello, MD, and S. L. Walsh, PhD. “Prescription Drug Fatalities Among Women in Rural Virginia: A Study of Medical Examiner Cases”. Journal of Opioid Management, vol. 5, no. 4, Jan. 2018, pp. 228-36, doi:10.5055/jom.2009.0025.

Issue

Section

Articles